Cambridge Diagnostics (Polska)sp. z o.o.

Agents involved in the sale of specialised goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2014-03-18
Share capital
100 000,00 PLN
Activity description

Cambridge Diagnostics (Polska) is a company that specializes in food intolerance testing, offering the FoodPrint® 220+ test to identify individual food intolerances. They also provide dietary consultations through their Dietetic Clinic and educational programs via the Cambridge Academy to enhance knowledge and skills related to health and nutrition.

Registered address
ul. Górnośląska 4A, 00-444 Warszawa, Poland
Website
Email
Email address current
Phone
Social media
Electronic delivery address
AE:PL-20632-51960-RUGUD-12

Financials

The financial statement for 2025 has not yet been filed with the Financial Document Repository (past deadline).

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue
This companyUSD 881.79kMedianUSD 223.73kAverageUSD 2.35m
Net profit
This companyUSD 136.40kMedianUSD 5.75kAverageUSD 144.55k
Operating costs
This companyUSD 726.35kMedianUSD 186.16kAverageUSD 2.11m
Assets
This companyUSD 1.41mMedianUSD 166.04kAverageUSD 1.41m

Bank accounts

Registered as a VAT taxpayer on 2014-05-01. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

104 public aid cases recorded, with a total value of $252,715.

PurposeGross amount
Aid in the form of wage subsidies for employing workers with disabilities
$1,029
Aid in the form of wage subsidies for employing workers with disabilities
$1,029
Aid in the form of wage subsidies for employing workers with disabilities
$1,029

Tenders

No recorded participation in tenders.

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Authorized Representatives

Stanley Adam Wajs — President of the Management Board
Alicja Drewnowska — Vice Prezes Zarządu
Justyna Lipińska — Management Board Member

Manner of representation

Each member of the management board acting independently is authorized to make declarations of will on behalf of the company, or the commercial proxy acting independently.

Ownership

OwnerSharesShare valueStake
Cambridge Diagnostics (uk) Limited
102$13,776.3451%
Alicja Drewnowska (72)
49$6,618.0424.5%
Stanley Adam Wajs (82)
49$6,618.0424.5%

Beneficial owners

Person
Alicja Drewnowska (72)
Stanley Adam Wajs (82)

Competitors

Name
Medmess Kropaczewskisp. k.
Bio-Novumsp. z o.o.
Pohl & Pohlsp. z o.o.
Citipharmsp. z o.o. + limited partnership
Primerissp. z o.o.
Zbadajsiesp. z o.o.
Performance Group Polandsp. z o.o.
Madmedsp. z o.o.
Food SectorP.S.A.
Screenmedsp. z o.o.

Change history

DateEvent
2025-08-20PKD change
2017-05-23Address change
2014-03-18Entered in the register

FAQ

Last updated: 2026-06-29